Lexicon Pharma (LXRX) Misses Q4 EPS by 5c
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) reported Q4 GAAP ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
